US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31

+0.55000.19%

Pre-market: 291.00-5.3100-1.79%07:10 EDT

Volume:260.53K

Turnover:75.10M

Market Cap:570.24M

PE:- -

High:300.34

Open:290.97

Low:281.50

Close:295.76

52wk High:341.93

52wk Low:71.88

Shares:1.92M

Float Shares:1.92M

Volume Ratio:0.69

T/O Rate:13.54%

Dividend:1.01

Dividend Rate:0.34%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley

Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley

Memphasys Accelerates Felix Launch After Early Thai FDA Approval

Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV

Health Care Down on Rotation to Tech

Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™

Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise

MT Newswires Live

Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.

Stryker to participate in the 2026 Wells Fargo Healthcare Conference

Is Sonic Healthcare’s (ASX:SHL) Bigger FY26 Profit And Dividend Reaffirming Or Recasting Its Investment Story?

Simply Wall St.

Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process

Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says

Sector Update: Healthcare

MT Newswires Live

Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth

Simply Wall St.

Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)

Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta

Sector Update: Healthcare

MT Newswires Live

Codexis to Participate in Cantor Global Healthcare Conference 2026

SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes

MT Newswires Live

Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/LABU/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LABU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","market":"US","secType":"STK","nameCN":"Direxion Daily S&P Biotech Bull 3x Shares","latestPrice":296.31,"timestamp":1788206400000,"preClose":295.76,"halted":0,"volume":260525,"hourTrading":{"tag":"盘前","latestPrice":291,"preClose":296.31,"latestTime":"07:10 EDT","volume":592,"amount":172619.39744,"timestamp":1788261005480,"change":-5.31,"changeRate":-0.01792,"amplitude":0.025967},"delay":0,"changeRate":0.0018596159047877042,"floatShares":1924486,"shares":1924486,"eps":0,"marketStatus":"Pre-Mkt","change":0.55,"latestTime":"09-01 07:18:29 EDT","open":290.97,"high":300.34,"low":281.5,"amount":75101085.83125001,"amplitude":0.0637,"askPrice":292.8,"askSize":200,"bidPrice":285.2,"bidSize":200,"shortable":3,"etf":3,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":296.31,"sharesOutstanding":3074486,"nav":295.545,"aum":568772231.45,"dividendRate":0.0034,"bidAskSpread":0.002847,"preHourTrading":{"tag":"盘前","latestPrice":291,"preClose":296.31,"latestTime":"07:10 EDT","volume":592,"amount":172619.39744,"timestamp":1788261005480,"change":-5.31,"changeRate":-0.01792,"amplitude":0.025967},"postHourTrading":{"tag":"盘后","latestPrice":295.02,"preClose":296.31,"latestTime":"19:59 EDT","volume":2518,"amount":745089.4272,"timestamp":1788220773434,"change":-1.29,"changeRate":-0.004354,"amplitude":0.010268},"volumeRatio":0.6867414366828442,"impliedVol":0.9253,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LABU\",,,,,undefined,":{"symbol":"LABU","floatShares":1924486,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.6867414366828442,"shares":1924486,"dividePrice":1.0075,"high":300.34,"amplitude":0.0637,"preClose":295.76,"low":281.5,"week52Low":71.88,"pbRate":"--","week52High":341.93,"institutionHeld":0,"latestPrice":296.31,"eps":0,"divideRate":0.0034,"volume":260525,"delay":0,"ttmEps":0,"open":290.97,"prevYearClose":159.39,"prevWeekClose":295.76,"prevMonthClose":296.31,"prevQuarterClose":292.1,"fiveDayClose":308.33,"twentyDayClose":228.04,"sixtyDayClose":179.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LABU\",params:#limit:5,,,undefined,":[{"date":"2025-09-23","symbol":"LABU","amount":0.10273,"announcedDate":"2025-09-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-23","defaultRemindTime":1758634200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-23","currency":"USD","dateTimestamp":1758600000000,"payDate":"2025-09-30"},{"date":"2025-06-24","symbol":"LABU","amount":0.21897,"announcedDate":"2025-06-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-24","defaultRemindTime":1750771800000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-24","currency":"USD","dateTimestamp":1750737600000,"payDate":"2025-07-01"},{"date":"2025-03-25","symbol":"LABU","amount":0.10714,"announcedDate":"2025-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-25","defaultRemindTime":1742909400000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-25","currency":"USD","dateTimestamp":1742875200000,"payDate":"2025-04-01"},{"date":"2024-06-25","symbol":"LABU","amount":0.15021,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-25","defaultRemindTime":1719322200000,"name":"三倍做多标普生物-Direxion","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-07-02","payableDate":"2024-06-25","currency":"USD","dateTimestamp":1719288000000,"payDate":"2024-07-02"},{"date":"2024-03-19","symbol":"LABU","amount":0.16064,"announcedDate":"2024-03-18","type":"dividend","market":"US","newRecordDate":"2024-03-20","defaultRemindTime":1710855000000,"name":"三倍做多标普生物-Direxion","recordDate":"2024-03-26","payableDate":"2024-03-20","currency":"USD","dateTimestamp":1710820800000,"payDate":"2024-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LABU\",market:\"US\",,,undefined,":[{"executeDate":"2018-06-19","recordDate":"2018-06-20","paymentDate":"2018-06-26","value":0.01932,"currency":"USD"},{"executeDate":"2018-09-25","recordDate":"2018-09-26","paymentDate":"2018-10-02","value":0.0954,"currency":"USD"},{"executeDate":"2018-12-27","recordDate":"2018-12-28","paymentDate":"2019-01-04","value":0.09621,"currency":"USD"},{"executeDate":"2019-03-19","recordDate":"2019-03-20","paymentDate":"2019-03-26","value":0.10973,"currency":"USD"},{"executeDate":"2019-06-25","recordDate":"2019-06-26","paymentDate":"2019-07-02","value":0.03745,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LABU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LABU\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662037042","title":"Sigma Healthcare Ltd (S5YA) Receives a Buy from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662037042","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662037042?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880935,"startTime":"0","endTime":"0","summary":"In a report released today, Melinda Baxter from Morgan Stanley maintained a Buy rating on Sigma Healthcare Ltd, with a price target of A$3.30. Acco...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/sigma-healthcare-ltd-s5ya-receives-a-buy-from-morgan-stanley-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","XLV","BK4581","LU0128526141.USD","BK4585","LABU","HCSG","BK4588","BK4137","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662020037","title":"Ramsay Health Care (RMSYF) Gets a Sell from Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2662020037","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662020037?lang=en_us&edition=fundamental","pubTime":"2026-08-28 09:35","pubTimestamp":1787880929,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst David Bailey maintained a Sell rating on Ramsay Health Care today and set a price target of A$40.90. According to TipRanks, ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ramsay-health-care-rmsyf-gets-a-sell-from-morgan-stanley-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["RMSYF","BK4585","BK4588","BK4581","XLV","XBI","LABU","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662031640","title":"Memphasys Accelerates Felix Launch After Early Thai FDA Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=2662031640","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662031640?lang=en_us&edition=fundamental","pubTime":"2026-08-28 07:18","pubTimestamp":1787872720,"startTime":"0","endTime":"0","summary":"Memphasys Ltd ( ($AU:MEM) ) has provided an update. Memphasys Limited has secured early approval from the Thai Food and Drug Administration for its...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/memphasys-accelerates-felix-launch-after-early-thai-fda-approval?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","MEM","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662036059","title":"Gilead’s Bixlenvo approved by FDA for virologically suppressed adults with HIV","url":"https://stock-news.laohu8.com/highlight/detail?id=2662036059","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662036059?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:55","pubTimestamp":1787867719,"startTime":"0","endTime":"0","summary":"Gilead (GILD) Sciences announced that the FDA approved Bixlenvo – bictegravir 75 mg/lenacapavir 50 mg -, the smallest once-daily single tablet regi...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/gileads-bixlenvo-approved-by-fda-for-virologically-suppressed-adults-with-hiv-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BSNM7G36.USD","LABU","LU0965509101.SGD","LU1674673428.USD","BK4532","LU0823416689.USD","IBB","LU1066053197.SGD","LU1934455194.USD","LU2357627491.SGD","BBH","BK4568","SG9999015986.USD","LU0861579265.USD","LU1066051498.USD","BK4588","LU0234570918.USD","LU0889565916.HKD","LU1037948897.HKD","BIB","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0859254822.USD","IE00B19Z3581.USD","BK4566","SG9999015952.SGD","TMED","LU0109394709.USD","LU1839511570.USD","IBBQ","GILD","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","MEDI","IE00B19Z3B42.SGD","LU1585245621.USD","BK4585","BMED","LU1674673691.USD","BK4583","LU2087621335.USD","SG9999015945.SGD","LU2324357040.USD","LU0965509283.SGD","TBXU","LU1571399168.USD","LU0122379950.USD","LU1934455863.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662603529","title":"Health Care Down on Rotation to Tech","url":"https://stock-news.laohu8.com/highlight/detail?id=2662603529","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662603529?lang=en_us&edition=fundamental","pubTime":"2026-08-28 05:26","pubTimestamp":1787865960,"startTime":"0","endTime":"0","summary":"Health-care companies fell as traders rotated out of defensive sectors back into the high-risk tech sector.Novo Nordisk shares slipped after analysts at brokerage Deutsche Bank cut their rating on the Ozempic maker, warning that a recent deceleration in sales growth could continue. Intensified competition from Eli Lilly and smaller rivals has weighed on the Danish giant's earnings in recent quarters, as it gives up some of its early lead on the wildly popular GLP-1 category of drugs.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4581","XLV","XBI","LABU","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662112039","title":"Outlook Therapeutics Appoints Kevin Lundquist as Chief Financial Officer as It Prepares for U.S. Commercial Launch of LYTENAVA™","url":"https://stock-news.laohu8.com/highlight/detail?id=2662112039","media":"GlobeNewswire","labels":["executive","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662112039?lang=en_us&edition=fundamental","pubTime":"2026-08-28 04:05","pubTimestamp":1787861100,"startTime":"0","endTime":"0","summary":"Kevin Lundquist   Kevin Lundquist  Seasoned finance executive brings more than 20 years of leadership experience across global commercial organizations, including the pharmaceutical and medical techno","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352397/0/en/outlook-therapeutics-appoints-kevin-lundquist-as-chief-financial-officer-as-it-prepares-for-u-s-commercial-launch-of-lytenava.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CNAV","WUGI","ILDR","AMDG","BK4512","PSI","ARTY","LU0133085943.USD","SMH","LABU","DAMD","AMDY","IETC","USXF","LU2896262040.SGD","AMYY","AIS","BAI","CHPS","AMUU","AMDL","BK4007","SGXZ51526630.SGD","SMHX","LENZ","SOXX","FAI","AMDD","QQQA","SAMD0main","IEIH","AIQ","LU1852331112.SGD","SGXZ81514606.USD","SOXY","WISE","LEGR","XNTK","TTEQ","AMDW","CHAT","AMDC","GAMR","TRFK","TEK","AMDU","AMD","LU0127658192.USD","AMDS","FTXL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662003883","title":"Roivant Sciences Gets FDA Approval for LISRAYA in Dermatomyositis; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2662003883","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662003883?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:58","pubTimestamp":1787860715,"startTime":"0","endTime":"0","summary":"Roivant Sciences (ROIV) said Thursday the FDA approved LISRAYA for adults with dermatomyositis, with the once-daily pill now available in the US, sending its shares up 1.5%.The approval follows the Ph","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","PTH","BK4007","BK4139","ROIV","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662008070","title":"Priovant Announces FDA Approval of LISRAYA™ (brepocitinib) for Adults with Dermatomyositis; Now Available in the U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2662008070","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662008070?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:28","pubTimestamp":1787858880,"startTime":"0","endTime":"0","summary":"LISRAYA represents the first major therapeutic innovation in decades for adults with dermatomyositis (DM), a debilitating systemic autoimmune diseaseLISRAYA is a once-daily pill that directly targets ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352364/34323/en/priovant-announces-fda-approval-of-lisraya-brepocitinib-for-adults-with-dermatomyositis-now-available-in-the-u-s.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4183","LABU","BK4585","BK4588","RA","BK4157","MACE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662080831","title":"Stryker to participate in the 2026 Wells Fargo Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662080831","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662080831?lang=en_us&edition=fundamental","pubTime":"2026-08-28 03:00","pubTimestamp":1787857200,"startTime":"0","endTime":"0","summary":"Portage, Michigan, Aug.  27, 2026  -- Stryker  will participate in the 2026 Wells Fargo Healthcare Conference on Tuesday, September 8, 2026, at the Encore Boston Harbor. Preston Wells, Vice President, Chief Financial Officer and Nick Mead, Vice President, Investor Relations will also participate in a fireside chat session at 2:15 p.m. . A simultaneous live audio webcast and replay of the session can be accessed atStryker - Events & Presentations. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com. Contacts For investor inquiries:Nick Mead, Vice President, Investor Relations at 269-385-2600 or nick.mead@stryker.com  For medi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352354/0/en/stryker-to-participate-in-the-2026-wells-fargo-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0029864427.USD","LU0640476718.USD","LU2506952097.USD","HCSG","LU0052756011.USD","FTXO","LU0070302665.USD","IYF","KBWB","LU1668664300.SGD","SYK","LU0868494708.USD","LU1506573853.SGD","LU1791807156.HKD","LABU","LU0128526141.USD","LU0211327993.USD","LU0211328371.USD","LU0106831901.USD","LU0787776722.HKD","LU0058720904.USD","LU0128525689.USD","LU0130102774.USD","IE00B19Z3581.USD","LU0289960550.SGD","BK4559","LU0432979614.USD","XLV","LU1280957306.USD","LU0690374961.EUR","LU1791710582.SGD","LU1791710400.SGD","TFNS","IE0002270589.USD","LU2324357040.USD","BK4582","LU0980610538.SGD","GB00B4QBRK32.GBP","PGF","LU0477156953.USD","LU2089984988.USD","BK4581","LU0310799852.SGD","XBI","LU0128525929.USD","WFC","IHI","LU1267930227.SGD","LU1267930573.SGD","LU1035773651.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662033368","title":"Is Sonic Healthcare’s (ASX:SHL) Bigger FY26 Profit And Dividend Reaffirming Or Recasting Its Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662033368","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662033368?lang=en_us&edition=fundamental","pubTime":"2026-08-28 02:39","pubTimestamp":1787855940,"startTime":"0","endTime":"0","summary":"Sonic Healthcare Limited has released its full-year results for the year ended June 30, 2026, reporting revenue of A$10.97 billion, net income of A$608.29 million and declaring a semi-annual dividend of A$0.63 per share, payable on September 17, 2026.\nThe combination of higher sales and earnings compared with the prior year and the confirmed dividend suggests the company is emphasizing both growth and ongoing cash returns to shareholders.\nNow we will examine how this higher full-year revenue...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6032000-choice2-main-header/1585186864566"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/is-sonic-healthcares-asxshl-bigger-fy26-profit-and-dividend","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-shl/sonic-healthcare-shares/news/is-sonic-healthcares-asxshl-bigger-fy26-profit-and-dividend","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["DECU","GXDW","AIPO","VGFPF","VOTE","XLV","LABU","RGLO","SHL.AU","BK7124","FEBU","BK4588","BK4585","XBI","PMDE","JOYT","BK4581"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662120082","title":"Replimune Group Lawsuit: Company Asks Court to Dismiss Securities Case Over RP1 FDA Approval Process","url":"https://stock-news.laohu8.com/highlight/detail?id=2662120082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662120082?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:35","pubTimestamp":1787852158,"startTime":"0","endTime":"0","summary":"Replimune Group, Inc. (NASDAQ: REPL) and several current or former company leaders have asked a federal court in Massachusetts to dismiss an invest...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-company-asks-court-to-dismiss-securities-case-over-rp1-fda-approval-process?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/replimune-group-lawsuit-company-asks-court-to-dismiss-securities-case-over-rp1-fda-approval-process?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ONEQ",".IXIC","QQQA","FTEC","QYLG","SQQQ","NVIW.SI","NDX","IYW","PSQ","JEPQ","TQQY","QQQJ","BK4139","TECS","QID","TQQQ","QQQM","QQQ","NQmain","BK4588","QLD","QDTE","BK4585","QQQE","QQQY","MNQmain","GPIQ","LABU","REPL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662111082","title":"Chemed unit claimed to misdiagnose dementia patients, Capitol Forum says","url":"https://stock-news.laohu8.com/highlight/detail?id=2662111082","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662111082?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:35","pubTimestamp":1787852110,"startTime":"0","endTime":"0","summary":"The Capitol Forum stated in a post to X: “Chemed (CHE): Vitas Healthcare Misdiagnosed Dementia Patients and ‘Fudged’ Evaluation Scores in Order to ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/chemed-unit-claimed-to-misdiagnose-dementia-patients-capitol-forum-says-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BLDYK493.USD","IE00B64QTZ34.USD","BK4585","FET","LU1543694498.USD","CHE","LABU","SOCL","LU1620156213.USD","BK4588","XBI","LU1165135440.EUR","LU2413665964.HKD","LU1721427968.SGD","LU1620156130.USD","XLV","LU1596574779.USD","BK4179","BK4581","LU2413666004.HKD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662017084","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662017084","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662017084?lang=en_us&edition=fundamental","pubTime":"2026-08-28 01:03","pubTimestamp":1787850204,"startTime":"0","endTime":"0","summary":"Healthcare stocks declined Thursday afternoon, with the NYSE Healthcare Index decreasing 0.8% and the State Street Health Care Select Sector SPDR ETF  shedding 0.7%.The iShares Biotechnology ETF  was fractionally lower.In corporate news, Moderna  shares fell 5.6% after it said Thursday it plans to offer $2 billion worth of convertible senior notes due 2032 in a private placement.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4532","BK4548","XBI","LU0029874061.USD","IBB","HCSG","BK4139","STT","BK4581","MRNX","BK4533","LU0128526141.USD","WDNA","MRNY","BK4585","BK4588","GNOM","BK4534","BK4501","BK4568","BK4137","LABU","IDNA","FDN","BK4551","XLV","LGHT","MRNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662808465","title":"Sigma Healthcare (ASX:SIG) Shares Drift As Margin Compression Tempers Profit Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2662808465","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662808465?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:40","pubTimestamp":1787845258,"startTime":"0","endTime":"0","summary":"Sigma Healthcare stock closed at A$2.62, with the shares drifting over the past month even as the company posted one of the stronger profit stories in Australian healthcare retail this season. The headline is simple: normalised net profit after tax reached A$732 million and normalised earnings per share came in at A$0.064, backed by a A$0.04 full year dividend.\nThe short term price softness now sits against a business that has lifted earnings faster than revenue and is running a trailing net...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6031000-choice1-main-header/1585186892307"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-sig/sigma-healthcare-shares/news/sigma-healthcare-asxsig-shares-drift-as-margin-compression-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4585","SIG.AU","LABU","XBI","BK4581","XLV","BK4588","BK7103"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662813780","title":"Analysts Offer Insights on Healthcare Companies: Verrica Pharmaceuticals (VRCA) and Amgen (AMGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2662813780","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662813780?lang=en_us&edition=fundamental","pubTime":"2026-08-27 23:20","pubTimestamp":1787844046,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Verrica Pharmaceuticals (VRCA) and Amgen (AMGN). Verrica Pharmace...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-verrica-pharmaceuticals-vrca-and-amgen-amgn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIB","IE00B4R5TH58.HKD","BK4137","HCSG","LU2242646821.SGD","LU1571399168.USD","BK4585","SG9999001440.SGD","IE0009355771.USD","BK4139","IE00BFTCPJ56.SGD","LABU","LU0128526141.USD","BK4599","BBH","LU0868494617.USD","LU0058720904.USD","LU2468319806.SGD","IE0002141913.USD","XLV","BK4588","LU0320765992.SGD","LU0122379950.USD","AMGN","LU1023059063.AUD","LU2112291526.USD","PBE","LU0889565916.HKD","TBXU","LU1983299246.USD","LU0289739699.SGD","VRCA","PJP","LU0109394709.USD","LU1057294990.SGD","BK4533","IE00B2B36J28.USD","LU2089984988.USD","BK4581","IBB","IBBQ","XBI","LU2242652126.USD","BK4534","IE00BJT1NW94.SGD","BK4566","IE00BJJMRZ35.SGD","LU0029874061.USD","BK4007","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662304088","title":"Healthcare Exec Lists $18.25 Million French Chateau-Style Home Outside Atlanta","url":"https://stock-news.laohu8.com/highlight/detail?id=2662304088","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662304088?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:11","pubTimestamp":1787836260,"startTime":"0","endTime":"0","summary":"For her 6th birthday party, Anna Windley had pony rides and a petting zoo at her parents' French chateau-style house outside Atlanta. Inside there was a playroom for Anna and her sister, Ava, complete","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HBCP","HCSG","LU0029874061.USD","LABU","BK4195","LU0128526141.USD","BK4137","XBI","XLV","BK4585","BK4211","BK4581","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662007177","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2662007177","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662007177?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:01","pubTimestamp":1787835662,"startTime":"0","endTime":"0","summary":"Healthcare stocks were declining pre-bell Thursday, with the State Street Health Care Select Sector SPDR ETF  0.7% lower and the iShares Biotechnology ETF  down 0.5%.Novo Nordisk  said China's National Medical Products Administration has accepted its marketing application for the oral version of its weight-loss drug Wegovy, Reuters reported. Novo Nordisk stock was down more than 2% premarket.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XLV","IBB","NVOX","LU0154236417.USD","NVO","LU1093756168.USD","IE00BZ1G4Q59.USD","BK4599","LU1093756325.SGD","IE00BKVL7J92.USD","BK4532","BK4007","BK4581","THNR","XBI","LABU","BK4585","BK4588","NVOC","PPH","OZEM","NVOH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662851820","title":"Codexis to Participate in Cantor Global Healthcare Conference 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2662851820","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662851820?lang=en_us&edition=fundamental","pubTime":"2026-08-27 21:00","pubTimestamp":1787835600,"startTime":"0","endTime":"0","summary":"REDWOOD CITY, Calif., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable manufacturing of complex therapeutics, today","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3352067/24825/en/codexis-to-participate-in-cantor-global-healthcare-conference-2026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","LABU","BK4121","BK4581","BK4137","CDXS","LU0029874061.USD","BK4588","EES"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662755707","title":"SL Science Files FDA Drug Master File for GDT Cell-Derived Exosomes","url":"https://stock-news.laohu8.com/highlight/detail?id=2662755707","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662755707?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:41","pubTimestamp":1787834466,"startTime":"0","endTime":"0","summary":"SL Science  said Thursday that its licensor, JY BioMed, filed a new drug master file with the US Food and Drug Administration covering exosomes derived from Gamma Delta T, or GDT, cells.The company said the filing, numbered 044612, adds manufacturing and quality documentation for the cell-free exosome format of the GDT technology, potentially streamlining regulatory work for future programs.SL Science said the exosomes could have potential applications in oncology, including brain cancer, as preclinical research suggests they can trigger tumor cell death, stimulate immune responses and cross the blood-brain barrier.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["SLBT","GDT","BK4585","LABU","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662856680","title":"Harmony Biosciences to Participate in 2026 Cantor Global Healthcare Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2662856680","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662856680?lang=en_us&edition=fundamental","pubTime":"2026-08-27 20:05","pubTimestamp":1787832300,"startTime":"0","endTime":"0","summary":"PLYMOUTH MEETING, Pa., Aug.  27, 2026 (GLOBE NEWSWIRE) -- Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that Harmony's management team will participate in a fireside chat at the 2","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/08/27/3351980/0/en/harmony-biosciences-to-participate-in-2026-cantor-global-healthcare-conference.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","HCSG","LABU","BK4588","BK4137","BK4585","XBI","LU0128526141.USD","BK4581","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":21,"pageCount":6,"totalSize":405,"code":"91000000","status":"200"}]}}